Comerica Bank
EWTX icon

Comerica Bank’s Edgewise Therapeutics EWTX Stock Holding History

Comerica Bank’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$890 Hold
35
– – ﹤0.01% 3593
2025
Q3 		$581 Hold
35
– – ﹤0.01% 3626
2025
Q2 		$470 Sell
35
-86
-71% -$1.24K ﹤0.01% 3620
2025
Q1 		$2.67K Buy
121
+13
+12% +$341 ﹤0.01% 3431
2024
Q4 		$2.88K Buy
+108
New +$3.44K ﹤0.01% 3420
2024
Q2 		– Sell
-57
Closed -$1.04K – 3736
2024
Q1 		$1.04K Buy
+57
New +$906 ﹤0.01% 3620

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Comerica Bank's EWTX Position: Q4 2025 in Review

Comerica Bank held its Edgewise Therapeutics (EWTX) position steady in Q4 2025 at 35 shares worth $890. The position accounts for ﹤0.01% of the portfolio, ranked #3593.

Comerica Bank first reported a position in EWTX in Q1 2024 and has held it in 6 quarters since. The position peaked at $2.88K in Q4 2024. 199 funds tracked by Wall St. Rank hold EWTX as of Q4 2025.

  • Comerica Bank held 35 shares of Edgewise Therapeutics worth $890 as of Q4 2025.
  • Comerica Bank left its Edgewise Therapeutics share count unchanged in Q4 2025.
  • Edgewise Therapeutics made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3593 holding.
  • Comerica Bank first reported a position in Edgewise Therapeutics in Q1 2024 and has held it in 6 quarters since.
  • Comerica Bank's Edgewise Therapeutics position peaked at $2.88K in Q4 2024.
  • 199 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.